We've noticed that you're using an ad blocker

Our content is brought to you free of charge because of the support of our advertisers. To continue enjoying our content, please turn off your ad blocker.

It's off now Dismiss How do I disable my ad blocker?
❌

How to disable your ad blocker for our site:

Adblock / Adblock Plus
  • Click on the AdBlock / AdBlock Plus icon on the top right of your browser.
  • Click “Don’t run on pages on this domain.” OR “Enabled on this site.”
  • Close this help box and click "It's off now".
Firefox Tracking Prevention
  • If you are Private Browsing in Firefox, "Tracking Protection" may casue the adblock notice to show. It can be temporarily disabled by clicking the "shield" icon in the address bar.
  • Close this help box and click "It's off now".
Ghostery
  • Click the Ghostery icon on your browser.
  • In Ghostery versions < 6.0 click “Whitelist site.” in version 6.0 click “Trust site.”
  • Close this help box and click "It's off now".
uBlock / uBlock Origin
  • Click the uBlock / uBlock Origin icon on your browser.
  • Click the “power” button in the menu that appears to whitelist the current website
  • Close this help box and click "It's off now".
  • ONCOLOGY
  • News
  • Blogs
  • Topics
  • Hematology
  • Image IQ
  • Podcasts
  • Videos
  • Slideshows
  • Conferences

Modern Medicine Network
  • Login
  • Register
Skip to main content
Modern Medicine Network
  • Login
  • Register
Menu
User
Home
  • ONCOLOGY
  • News
  • Blogs
  • Topics
  • Hematology
  • Image IQ
  • Podcasts
  • Videos
  • Slideshows
  • Conferences

SUBSCRIBE: Print / eNewsletter

NCI Scientists Find Specific Mutation in the Breast Cancer Gene

Nov 1, 1995
Volume: 
4
Issue: 
11
  • Breast Cancer

BETHESDA, Md-Scientists from the National Cancer Institute have
found a specific mutation, 185delAG, in the breast cancer 1 gene
(BRCA1) in almost 1% of DNA samples from a study group of Eastern
European (Ashkenazi) Jews. This is the first time that scientists
have been able to show that the gene mutation is present at measurable
levels not only in high-risk families but also in a specific group
of the general population.

At a press conference, Donna Shalala, secretary of the US Department
of Health and Human Services, said that "this exciting finding
should allow us to move rapidly toward our goal of identifying
high-risk women and helping them to prevent breast cancer before
it strikes."

The study, an international collaboration between the National
Center for Human Genome Research (NCHGR), the NCI, the Sarett
Institute (Jerusalem), and the University of California, San Diego,
involved 858 unrelated Ashkenazi Jews from the United States and
Israel whose family or personal cancer histories were not known.

Eight (1%) of the individuals tested were found to have the 185delAG
mutation. This rate of alteration in the BRCA1 gene is three times
higher than all BRCA1 alterations combined in the general population.
Scientists did not find the alteration in 815 other samples from
individuals not selected for ethnic origins.

Dr. Jeffery Struewing, lead author of the report (Nature Genetics,
October, 1995), cautioned that the results were too preliminary
to recommend immediate BRCA1 testing for the nation's 5.5 million
Ashkenazi Jews. However, NIH has announced plans to launch a series
of clinical studies to evaluate cancer risk in Ashkenazi Jews
bearing the mutation.

Related Articles

  • Prognostic Tool Can Guide Extended Endocrine Therapy in ER+ Breast Cancer
  • Forecasting PARP Inhibitor Resistance in Breast Cancer Patients
  • OncoMasTR Assay May Help Some Breast Cancer Patients Avoid Chemo
  • RAD51 Linked With PARP Inhibitor Resistance in BRCA-Mutated Breast Cancer
  • HER2+ Breast Cancer Subtypes Resistant to TKIs Through Differing Mechanisms

Resource Topics rightRail

  • Resource Topics
  • Partner Content
Breast Cancer
Lung Cancer
Prostate Cancer
Colorectal Cancer
Melanoma
Cutaneous T-Cell Lymphomas: Mycosis Fungoides and Sézary Syndrome
3 Keys to Success in the Oncology Care Model

Current Issue

Oncology Vol 32 No 4
Apr 15, 2018 Vol 32 No 4
Digital Edition
Subscribe
Connect with Us
  • Twitter
  • Facebook
  • LinkedIn
  • RSS
Modern Medicine Network
  • Home
  • About Us
  • Advertise
  • Advertiser Terms
  • Privacy statement
  • Terms & Conditions
  • Editorial & Advertising Policy
  • Editorial Board
  • Contact Us
Modern Medicine Network
© UBM 2018, All rights reserved.
Reproduction in whole or in part is prohibited.